Text Size
1965 studies found for:    Open Studies | "Drug Therapy"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Drug Therapy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
Conditions: Sarcoma;   Chemotherapy-induced Nausea and Vomiting;   Effects of Chemotherapy;   Adverse Effects of Medical Drugs
Interventions: Drug: Fosaprepitant;   Drug: Dexamethasone;   Drug: 5HT3 receptor antagonist;   Drug: Ifosfamide-based chemotherapy (AI);   Drug: Doxorubicin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Vincristine
2 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
3 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
4 Recruiting Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: dexamethasone
5 Recruiting Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting
Conditions: Breast Cancer;   Malignant Female Reproductive System Neoplasm;   Lymphomas;   Chemotherapy-induced Nausea and Vomiting
Interventions: Behavioral: yoga;   Behavioral: Jacobsons PMRT group
6 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Zofran inj.+Zofran tab.
7 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
8 Recruiting Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab
Conditions: Breast Cancer;   HER-2 Positive Breast Cancer;   Effects of Chemotherapy
Intervention: Drug: Nab-paclitaxel
9 Unknown † A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
10 Recruiting Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
11 Unknown † Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Conditions: Chemotherapy;   Breast Cancer, Metastatic
Intervention: Drug: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
12 Recruiting Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Bevacizumab;   Neoadjuvant Chemotherapy;   Molecular Targeted Therapy
Intervention: Drug: bevacizumab
13 Recruiting A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Conditions: Non-myeloid Malignancies;   Chemotherapy Induced Anaemia
Interventions: Drug: iron isomaltoside 1000;   Drug: iron sulphate
14 Recruiting Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
15 Recruiting LYmphadenectomy After NeoAdjuvant Chemotherapy
Condition: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Intervention: Procedure: Systematic pelvic and aortic lymphadenectomy
16 Recruiting Characterization and Treatment of Chemotherapy Neuropathy
Condition: Chemotherapy-induced Neuropathy
Interventions: Procedure: Photon stimulation;   Procedure: Placebo treatment
17 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Kytril inj.+Kytril tab.
18 Not yet recruiting Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Conditions: Newly Diagnosed;   Advanced Ovarian Cancer;   FIGO Stage II-IV;   BRCA Mutation;   Complete Response;   Partial Response;   First Line Platinum Chemotherapy
Intervention: Drug: Olaparib 300mg tablets
19 Unknown † Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34
20 Recruiting Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years